| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 471.88B | 486.80B | 468.24B | 494.74B | 655.26B | 613.89B |
| Gross Profit | 92.55B | 90.93B | 86.99B | 82.60B | 127.92B | 104.56B |
| EBITDA | 48.76B | 18.26B | 62.81B | 23.63B | 74.39B | 59.97B |
| Net Income | -5.26B | -4.82B | 28.98B | -7.01B | 24.50B | 22.94B |
Balance Sheet | ||||||
| Total Assets | 847.25B | 865.67B | 789.03B | 731.64B | 837.95B | 769.71B |
| Cash, Cash Equivalents and Short-Term Investments | 42.42B | 115.97B | 36.36B | 31.18B | 79.49B | 80.30B |
| Total Debt | 311.43B | 330.54B | 213.43B | 218.14B | 241.81B | 214.77B |
| Total Liabilities | 437.23B | 453.66B | 359.68B | 349.98B | 443.92B | 389.07B |
| Stockholders Equity | 392.88B | 395.10B | 408.75B | 361.71B | 369.65B | 359.56B |
Cash Flow | ||||||
| Free Cash Flow | 2.12B | -23.09B | 21.99B | -8.70B | -3.67B | 27.85B |
| Operating Cash Flow | 55.06B | 35.84B | 52.96B | 18.13B | 32.71B | 66.05B |
| Investing Cash Flow | -122.17B | -63.15B | -33.32B | -26.02B | -43.37B | -39.43B |
| Financing Cash Flow | 73.89B | 105.85B | -15.71B | 2.44B | 8.37B | 10.85B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $549.88B | 13.28 | 6.42% | 3.53% | -6.27% | 40.98% | |
72 Outperform | $317.10B | 8.80 | 9.65% | 4.21% | 0.87% | 16.71% | |
71 Outperform | $343.22B | 12.27 | 7.05% | 2.75% | -0.63% | ― | |
70 Neutral | $271.12B | 11.35 | 8.86% | 2.66% | -0.04% | 3.15% | |
62 Neutral | $101.52B | 36.06 | ― | 3.50% | -0.62% | -25.56% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
51 Neutral | $218.85B | -41.36 | -1.26% | 4.85% | -0.53% | -117.46% |
UBE Corporation has announced an accelerated schedule for its structural reforms at its Thailand base, initially planned for March 2027, now set for March 2026. This involves ceasing production of several chemical products and downsizing operations due to a sluggish business environment. The financial impact of these changes on the fiscal year ending March 2026 is under review, with potential further announcements if necessary.
The most recent analyst rating on (JP:4208) stock is a Hold with a Yen2500.00 price target. To see the full list of analyst forecasts on UBE Industries stock, see the JP:4208 Stock Forecast page.
UBE Corporation, a diversified chemical company listed on the Tokyo Stock Exchange, operates primarily in the specialty chemicals sector, focusing on products such as polymers, chemicals, and machinery. The company is known for its strategic investments in specialty businesses and its commitment to environmental contributions.
UBE Corporation reported a decrease in net sales and profits for the first quarter of 2025 compared to the previous year, with net sales dropping by 12.9% and profit attributable to owners of the parent decreasing by 9.2%. Despite these declines, the company has expanded its scope of consolidation by including seven new subsidiaries, indicating a strategic move to enhance its market position and operational capabilities.
The most recent analyst rating on (JP:4208) stock is a Hold with a Yen2900.00 price target. To see the full list of analyst forecasts on UBE Industries stock, see the JP:4208 Stock Forecast page.